10x Genomics (TXG) Debt Ratio (2018 - 2019)
10x Genomics recorded quarterly Debt Ratio of 0.05 in Q4 2019, down 5.37% quarter-over-quarter from 0.05 in Q3 2019, and down 79.45% year-over-year from 0.24 in Q4 2018.
10x Genomics' Debt Ratio history runs 2 years deep, the most recent figure standing at 0.05 for Q4 2019.
- In Q4 2019, Debt Ratio fell 79.45% year-over-year to 0.05; the TTM figure through Dec 2019 stood at 0.05 (down 79.45% YoY), while the FY2019 annual figure was 0.05, down 79.45% from the prior year.
- Debt Ratio came in at 0.05 for Q4 2019 at 10x Genomics, down from 0.05 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.24 in Q4 2018 to a low of 0.05 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 0.40 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 0.29 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 0.25 |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.05 |
| Sep 30, 2019 | 0.05 |
| Dec 31, 2018 | 0.24 |